<DOC>
	<DOCNO>NCT01737944</DOCNO>
	<brief_summary>Pharmacokinetics ( PK ) study</brief_summary>
	<brief_title>Exposure Study Comparing 3 Routes Methotrexate ( MTX ) Administration</brief_title>
	<detailed_description>To compare pharmacokinetic ( PK ) profile methotrexate ( MTX ) follow subcutaneous ( SC ) injection MTX use Vibex device obtain SC injection MTX without use device obtain intramuscular ( IM ) injection MTX adult subject rheumatoid arthritis ( RA ) .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Male female &gt; 18 year age diagnose Rheumatoid Arthritis ( RA ) . Chronic acute renal disease Any clinically significant disease disorder , opinion investigator , might put subject risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>methotrexate injection , subcutaneous , autoinjector</keyword>
</DOC>